Michelle Esser, program manager for research and advocacy, Young Survival Coalition, discusses two encouraging studies presented during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO).
Michelle Esser, program manager for research and advocacy, Young Survival Coalition, discusses two encouraging studies presented during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO), a Chicago gathering of nearly 30,000 oncology professionals in May and June.
Esser was particularly encouraged by discussions surrounding ovarian suppression, surgery and bisphosphonate use in premenopausal women with breast cancer. Esser also mentions a study conducted by Hatem Abdel Azim that looked at genetic differences in breast cancer of young and older women.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Listen